Insulin lispro-aabc

CHEBI:CHEBI_747566

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2380268
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
package_marketing_start_date
15-JUN-20
route
INTRAVENOUS
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
A-S Medication Solutions
manufacturer_name
A-S Medication Solutions
active_ingredient_name
INSULIN LISPRO
active_ingredient_strength
200 [iU]/mL
unii
GFX7QIS1II
nui
N0000175453
pharm_class_epc
Insulin Analog [EPC]
pharm_class
Insulin [Chemical/Ingredient]
pharm_class_cs
Insulin [Chemical/Ingredient]
marketing_start_date
20200615
brand_name_suffix
KwikPen
generic_name
Insulin lispro-aabc
brand_name
LYUMJEV KwikPen
brand_name_base
LYUMJEV
product_ndc
0002-8228
application_number
BLA761109
spl_id
0459e927-4328-44b2-946d-57c6e8d79977
package_ndc
0002-8228-27
package_description
2 SYRINGE in 1 CARTON (0002-8228-27) / 3 mL in 1 SYRINGE (0002-8228-01)
spl_set_id
616daea1-0b79-4970-a141-6f99f2072f02
upc
0300027728018
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class